Navigation Links
Pennsylvania Department of Health Opens Application Process for Research Funding to Treat Childhood Seizures

HARRISBURG, Pa., Nov. 18, 2015 /PRNewswire-USNewswire/ -- The Department of Health has opened the application process for expanded research into the use of Cannabidiol (CBD) for the treatment of children with intractable seizures.

Qualified research facilities are invited to compete for $2 million in funding from the Commonwealth Universal Research Enhancement Program (CURE) to support the study of CBD in treating children with epilepsy and other neurological diseases who suffer from medication-resistant seizures.

In November 2014, $2 million in CURE funding from the Tobacco Master Settlement Agreement of 1998 was placed in budgetary reserve for so-called "non-formula" priorities.

Following the success of several small pilot studies, the Department of Health determined that the continued study of CBD for the treatment of seizure frequency would be a priority for the agency.

"Treatment-resistant seizures are especially tragic when they affect children. The inability to control or stop seizure activity has a devastating impact on quality of life of pediatric patients," said Health Secretary Karen Murphy. "The goal of funding this research is to provide expanded – and compassionate -- access to CBD for children with intractable seizures in the hope that they are relieved of their pain and suffering."

The department has entered into an agreement with a manufacturer of pharmaceutical grade CBD. This manufacturer will provide a course of treatment for fifty pediatric patients at no cost to the awardee. The drug, in turn, must be provided to the study participant at no cost. The awardees will work directly with the manufacturer to secure, manage, and distribute the drug in accordance with its United States Food and Drug Administration's (FDA) approved expanded access drug status.

The funding will be made available in the summer of 2016.

CBD is a natural cannabinoid and one of over 400 natural chemical compounds found within the Cannabis Sativa plant. When isolated, the CBD compound has no psychotropic effects in humans and initial studies indicate it may possess a variety of pharmaceutical benefits, including reduction in seizure frequency.

The Request for Applications (RFA) document is posted on the Department of General Services emarketplace website at The deadline is December 8.

MEDIA CONTACT: Amy Worden, DOH, 717-787-1783


SOURCE Pennsylvania Department of Health
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Pennsylvania Physicians Urge State Legislators to Support Immunization Expansion Bill
2. Report: Upgrading Medicaid Drug Benefits Could Save Pennsylvania $896 Million
3. Wrong-Patient Medication Errors Examined by the Pennsylvania Patient Safety Authority
4. Center for Organ Recovery & Education Renews Call for Pennsylvania State Lawmakers to Support Donate Life PA Act
5. CHPA Applauds Pennsylvanias Adoption of Real-Time, Stop-Sale Technology, An Effective Tool in the Fight Against Methamphetamine
6. Pennsylvania Governor Corbett: Specialized Medical Company to Relocate Headquarters and Customer Service Center
7. Pharmacy Access Coalition Urges Pennsylvania General Assembly to Support Measure Expanding Access to Vaccines
8. Pennsylvania Department of Drug and Alcohol Programs Urges Participation in National Drug Take Back Day Events This Week
9. Highmark executive Michael Fiaschetti Appointed to Board of Pennsylvania eHealth Partnership Authority
10. Stakeholders elect ex-officio members to Board of Pennsylvania eHealth Partnership Authority
11. New Pennsylvania Hospital Opens, MEMdata Equipment Planning Utilized
Post Your Comments:
(Date:6/19/2019)... , ... June 19, 2019 , ... ... exclusively for the promotion of social welfare and protection of physicians’ rights, asserts ... than the previous revision and still rely on narrow guidelines as a basis ...
(Date:6/19/2019)... ... June 19, 2019 , ... Center for Vein Restoration (CVR) CEO and Founder, ... CEOs in 2019 . Glassdoor , one of the world’s largest job ... leaders that employees love working for throughout North America and parts of Europe. Dr. ...
(Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
Breaking Medicine Technology:
(Date:6/25/2019)... DETROIT (PRWEB) , ... June 25, 2019 , ... Women’s ... and raised in Louisiana and has been a practicing midwife for over 3 years. ... years. April received her Master’s in Nursing from Frontier University and her undergraduate from ...
(Date:6/25/2019)... ... June 25, 2019 , ... Smile Brands Inc., one of ... than 400 affiliated offices across 17 states, is pleased to announce its latest ... will provide full-service administrative support to the practice, which includes purchasing, payroll, accounting, ...
(Date:6/25/2019)... ... June 25, 2019 , ... The Global Smile Foundation will ... July thanks to 15-year-old Kylie Azizzadeh’s efforts fundraising for the mission. She has already ... before the mission takes place on July 15, 2019. , In 2018, Kylie ...
(Date:6/24/2019)... ... 2019 , ... innovaTel Telepsychiatry, a leading provider of psychiatric ... Advisory Board (SAB) to help inform the Company’s efforts to bring telepsychiatry services ... , We are honored to announce that Linda Rosenberg, immediate past President and ...
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... Exercising on ... cardio, people often try to mitigate this by running on softer surfaces, such as ... made of a rubber composite. Why not be able to have shock-absorption benefits ...
Breaking Medicine News(10 mins):